nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cardiac remodeling in systemic hypertension
|
Kenchaiah, Satish |
|
2004 |
88 |
1 |
p. 115-130 16 p. |
artikel |
2 |
Contents
|
|
|
2004 |
88 |
1 |
p. vii-xi nvt p. |
artikel |
3 |
Continued importance of diuretics and β-adrenergic blockers in the management of hypertension
|
Moser, Marvin |
|
2004 |
88 |
1 |
p. 167-187 21 p. |
artikel |
4 |
Coronary flow reserve measurements in hypertension
|
Kelm, Malte |
|
2004 |
88 |
1 |
p. 99-113 15 p. |
artikel |
5 |
Evolving role of calcium antagonists in themanagement of hypertension
|
Epstein, Murray |
|
2004 |
88 |
1 |
p. 149-165 17 p. |
artikel |
6 |
Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system
|
González, Arantxa |
|
2004 |
88 |
1 |
p. 83-97 15 p. |
artikel |
7 |
Forthcoming issues
|
|
|
2004 |
88 |
1 |
p. iv- 1 p. |
artikel |
8 |
Index
|
|
|
2004 |
88 |
1 |
p. 239-244 6 p. |
artikel |
9 |
Innovative concepts of hypertension to understand and manage the disease
|
Frohlich, Edward D. |
|
2004 |
88 |
1 |
p. xiii-xxi nvt p. |
artikel |
10 |
Insulin and insulin resistance:
|
Sowers, James R |
|
2004 |
88 |
1 |
p. 63-82 20 p. |
artikel |
11 |
Present status of genetic mechanisms in hypertension
|
Luft, Friedrich C |
|
2004 |
88 |
1 |
p. 1-18 18 p. |
artikel |
12 |
Primary prevention of essential hypertension
|
Krousel-Wood, Marie A |
|
2004 |
88 |
1 |
p. 223-238 16 p. |
artikel |
13 |
Renal function in the patient with hypertension
|
Hollenberg, Norman Kenneth |
|
2004 |
88 |
1 |
p. 131-140 10 p. |
artikel |
14 |
Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin
|
Savoia, Carmine |
|
2004 |
88 |
1 |
p. 39-62 24 p. |
artikel |
15 |
Target organ involvement in hypertension: a realistic promise of prevention and reversal
|
Frohlich, Edward D |
|
2004 |
88 |
1 |
p. 209-221 13 p. |
artikel |
16 |
Tissue renin angiotensin systems
|
Re, Richard N |
|
2004 |
88 |
1 |
p. 19-38 20 p. |
artikel |
17 |
What can we expect from new guidelines?
|
Kaplan, Norman M |
|
2004 |
88 |
1 |
p. 141-148 8 p. |
artikel |
18 |
What have we learned from the current trials?
|
Abbott, Kevin C |
|
2004 |
88 |
1 |
p. 189-207 19 p. |
artikel |